There's an unsung success story about the first year of the COVID-19 pandemic. At its outset, U.S. hospitals faced huge challenges, as influxes of patients strained resources, while doctors were ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates ...

Medicare beneficiaries with cardiovascular disease or risk factors had increased mortality rates and fewer hospitalizations ...

During the first two pandemic years, 1,008,012 people were diagnosed with cancer—473,781 in 2020 and 534,231 in 2021. Overall, one-year CSS was 84.8% in 2020 and 85.7% in 2021.

Findings are in line with documented impacts on screening, diagnosis, and treatment ...

A separate 2024 study in the Journal of the National Cancer Institute documented a dip in one-year survival for patients ...

A common vaccine could help to fight cancer, a new study suggests. For cancer patients undergoing immunotherapy, researchers found that receiving the mRNA COVID-19 vaccine within about 100 days of ...

JAMA study finds cancer patients diagnosed during COVID had lower first-year survival rates, likely due to screening and ...

In this study, researchers used the SEER-21 database to calculate 1-year cause-specific survival rates in patients diagnosed with a first primary malignant cancer between January 1, 2020, and December ...

CHARLOTTE, N.C. — A new study suggests the next big breakthrough in cancer treatment might come from a familiar source. Researchers at University of Florida found that patients with advanced lung or ...

A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...